Insight Molecular Valuation
| IMDX Stock | 2.84 0.19 6.27% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Insight Molecular retains a regular Real Value of USD2.63 per share. The prevalent price of the firm is USD2.84. Our model calculates the value of Insight Molecular from evaluating the firm fundamentals such as Return On Asset of -0.22, shares outstanding of 28.6 M, and Return On Equity of -4.29 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Insight Molecular's valuation include:
Price Book 8.0049 | Enterprise Value | Enterprise Value Ebitda (1.25) | Price Sales 22.549 | Enterprise Value Revenue 14.1147 |
Overvalued
Today
Please note that Insight Molecular's price fluctuation is dangerous at this time. Calculation of the real value of Insight Molecular is based on 3 months time horizon. Increasing Insight Molecular's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Insight Molecular is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Insight Stock. However, Insight Molecular's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.84 | Real 2.63 | Hype 2.84 | Naive 2.78 |
The intrinsic value of Insight Molecular's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Insight Molecular's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Insight Molecular Diagnostics helps investors to forecast how Insight stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Insight Molecular more accurately as focusing exclusively on Insight Molecular's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Insight Molecular's intrinsic value based on its ongoing forecasts of Insight Molecular's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Insight Molecular's closest peers.
Insight Molecular Cash |
|
Insight Valuation Trend
Analysing the historical paterns of Insight Molecular's enterprise value and its market capitalization is a good way to estimate and gauge the value of Insight Molecular Diagnostics over time and is usually enough for investors to make rational market timing decisions.
Insight Valuation Data Drivers
Insight Molecular Total Value Analysis
Insight Molecular Diagnostics is currently forecasted to have valuation of 54.24 M with market capitalization of 86.66 M, debt of 3.66 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Insight Molecular fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
54.24 M | 86.66 M | 3.66 M |
Insight Molecular Investor Information
About 22.0% of the company shares are held by company insiders. The company recorded a loss per share of 3.79. Insight Molecular had not issued any dividends in recent years. The entity had 1:20 split on the 25th of July 2023. Based on the analysis of Insight Molecular's profitability, liquidity, and operating efficiency, Insight Molecular Diagnostics may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Insight Molecular Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Insight Molecular has an asset utilization ratio of 5.36 percent. This suggests that the Company is making USD0.0536 for each dollar of assets. An increasing asset utilization means that Insight Molecular Diagnostics is more efficient with each dollar of assets it utilizes for everyday operations.Insight Molecular Ownership Allocation
Insight Molecular Diagnostics has a total of 28.6 Million outstanding shares. Over half of Insight Molecular's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Insight Molecular Profitability Analysis
The company reported the previous year's revenue of 1.88 M. Net Loss for the year was (60.66 M) with profit before overhead, payroll, taxes, and interest of 2.09 M.About Insight Molecular Valuation
Our relative valuation model uses a comparative analysis of Insight Molecular. We calculate exposure to Insight Molecular's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Insight Molecular's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 740 K | 777 K | |
| Pretax Profit Margin | (32.25) | (33.86) | |
| Operating Profit Margin | (32.45) | (34.07) | |
| Net Loss | (32.25) | (33.86) | |
| Gross Profit Margin | 0.39 | 0.41 |
Insight Molecular Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 13.1 M |
Insight Molecular Current Valuation Indicators
Valuation refers to the process of determining the present value of Insight Molecular Diagnostics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Insight we look at many different elements of the entity such as Insight's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Insight Molecular, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Insight Molecular's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Insight Molecular's worth.Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.